5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 10.50▲ | 10.77▼ | 10.76▼ | 9.85▲ | 6.59▲ |
MA10 | 10.59▼ | 10.73▼ | 10.58▲ | 7.98▲ | 3.98▲ |
MA20 | 10.75▼ | 10.47▲ | 10.73▼ | 5.59▲ | 2.65▲ |
MA50 | 10.50▲ | 9.96▲ | 9.01▲ | 3.01▲ | 19.42▼ |
MA100 | 10.73▼ | 8.55▲ | 6.35▲ | 2.24▲ | 63.95▼ |
MA200 | 10.20▲ | 6.21▲ | 4.31▲ | 12.08▼ | 146.03▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.048▼ | -0.019▼ | -0.106▼ | 0.600▲ | 2.641▲ |
RSI | 48.358▼ | 51.131▲ | 55.760▲ | 68.903▲ | 54.465▲ |
STOCH | 31.739 | 65.047 | 60.774 | 72.885 | 62.938 |
WILL %R | -54.167 | -47.348 | -82.614▼ | -30.851 | -27.967 |
CCI | -34.197 | -20.034 | -21.023 | 94.563 | 224.246▲ |
Sunday, June 29, 2025 10:00 PM
LAGUNA HILLS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to ...
|
Sunday, June 29, 2025 05:00 PM
Get the latest Eyenovia, Inc. (EYEN) stock news and headlines to help you in your trading and investing decisions.
|
Sunday, June 29, 2025 05:00 PM
NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 11.00 | 11.205 | 9.8201 | 10.56 | 1,169,948 |
30/06/25 | 11.47 | 14.33 | 9.7301 | 10.38 | 3,948,264 |
27/06/25 | 8.38 | 12.37 | 8.04 | 10.88 | 6,058,116 |
26/06/25 | 9.375 | 9.75 | 7.5031 | 7.89 | 1,931,889 |
25/06/25 | 8.955 | 11.40 | 8.0901 | 9.55 | 9,388,849 |
24/06/25 | 6.125 | 10.75 | 5.60 | 9.02 | 41,871,317 |
23/06/25 | 4.89 | 6.64 | 4.57 | 5.48 | 13,023,661 |
20/06/25 | 4.60 | 4.675 | 3.68 | 4.21 | 2,329,293 |
18/06/25 | 5.255 | 6.73 | 4.20 | 4.83 | 7,282,125 |
17/06/25 | 3.06 | 8.21 | 3.06 | 6.97 | 29,938,045 |
|
|
||||
|
|
||||
|
|